|[April 21, 2017]
Global Tamoxifen Market to Reach $683.6 Million by 2022: Key Vendors are AstraZaneca, Teva Pharmaceutical Industries, Allergan, Mylan, Apotex & Midatech - Research and Markets
Research and Markets has announced the addition of the "Global
Tamoxifen Market - 2014 to 2022" report to their offering.
The tamoxifen market was valued at USD 675.7 Mn in 2015, and is expected
to reach USD 683.6 Mn by 2022, expanding at a CAGR of 0.07% from 2016 to
Tamoxifen is the oldest and among the most prescribed selective estrogen
receptor modulator for breast cancer treatment and management. Tamoxifen
is approved for early stage, hormone receptor positive breast cancer in
men and women, after surgery or chemotherapy to reduce recurrence risk,
and for management of advanced stage or metastatic hormone-receptor
positive breast cancer. Women at high risk of developing breast cancer
also use Tamoxifen. Tamoxifen is at the maturity stage of product life
cycle and is anticipated to experience decline in market growth in the
light of introduction of advanced brast cancer management drugs.
This report analyzes the geographical distribution of tamoxifen market
in North America, Europe, Asia-Pacific and Rest of the World markets.
Currently, North America is the largest market for tamoxifen drugs and
it is anticipated that the lead of this region will continue through
2022. Large pool of breast cancer patients, high awareness for breast
cancer screening and prevention, well-structured reimbursement scenario
and large pool of breast cancer patients. Asia-Pacific and Rest of the
World markets will experience the fastest CAGR during 2016-2022.
Improving awareness in Middle East and Africa, high incidence of late
stage breast cancer in these regions and rapid development of healthcare
infrastructure are the prime drivers of Rest of the World market.
Astra Zeneca plc
Mylan Pharmaceuticals, Inc.
Teva Pharmaceutical Industries Ltd.
Key Topics Covered:
Chapter 1 Preface
Chapter 2 Executive Summary
Chapter 3 Tamoxifen: Market Dynamics and Outlook
Chapter 4 Global Tamoxifen Market, Pipeline Analysis
Chapter 5 Global Tamoxifen Market, by Geography
Chapter 6 Company Profiles
For more information about this report visit http://www.researchandmarkets.com/research/sjxh5r/global_tamoxifen
View source version on businesswire.com: http://www.businesswire.com/news/home/20170421005532/en/
[ Back To TMCnet.com's Homepage ]